एपीए उद्धरण

Choi, H., Choi, S., Back, Y. W., Paik, S., Park, H., Kim, W. S., . . . Kim, H. (2017). Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice. Oncotarget.

शिकागो स्टाइल उद्धरण

Choi, Han-Gyu, et al. "Rv2299c, a Novel Dendritic Cell-activating Antigen of Mycobacterium Tuberculosis, Fused-ESAT-6 Subunit Vaccine Confers Improved and Durable Protection against the Hypervirulent Strain HN878 in Mice." Oncotarget 2017.

एमएलए उद्धरण

Choi, Han-Gyu, et al. "Rv2299c, a Novel Dendritic Cell-activating Antigen of Mycobacterium Tuberculosis, Fused-ESAT-6 Subunit Vaccine Confers Improved and Durable Protection against the Hypervirulent Strain HN878 in Mice." Oncotarget 2017.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.